You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Merck
Johnson and Johnson
Moodys
Boehringer Ingelheim

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Litigation Details for PROMETHEUS LABORATORIES INC. v. ROXANE LABORATORIES, INC. (D.N.J. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in PROMETHEUS LABORATORIES INC. v. ROXANE LABORATORIES, INC.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for PROMETHEUS LABORATORIES INC. v. ROXANE LABORATORIES, INC. (D.N.J. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-03-04 1 the expiration of United States Patent No. 6,284,770 (the “’770 patent”) owned by Prometheus. Case 2…States Patent (10) Patent No.: US 6,284,770 BI …States Patent (10) Number: US 6,284,770 Cl Mangel…patients with alosetron, a 5-HT3 Patent No.: 6,284,770 receptor… US 6,284,770 Bl 1 External link to document
2012-10-05 194 Prehearing Statement Regarding United States Patent Nos. 6,284,770 and 6,175,014 by PROMETHEUS LABORATORIES…2011 3 June 2014 2:11-cv-01241-KM-MAH Patent None District Court, D. New Jersey External link to document
2012-10-10 197 motion concerning the invalidity of U.S. patent No. 6,284,770 be adjourned; etc. Signed by Judge Faith…dispositive motion concerning noninfringement of U.S. Patent No. 6,175,014 be adjourned from 10/22/12 to 11/…2011 3 June 2014 2:11-cv-01241-KM-MAH Patent None District Court, D. New Jersey External link to document
2013-02-08 283 Trial Regarding Legal Issues Related To U.S. Patent No. 6,284,770, # 2 Memorandum of Law In Support of Prometheus…Trial Regarding The Prosecution History Of U.S. Patent No. 6,175,014, # 3 Memorandum of Law In Support…2011 3 June 2014 2:11-cv-01241-KM-MAH Patent None District Court, D. New Jersey External link to document
2013-05-23 309 Not Infringe the Asserted Claims of U.S. Patent No. 6,284,770 Because a "Single Actor" Will Not Perform…Label Preparation, and Reexamination of the '770 Patent, # 3 Declaration of L. Nguyen, # 4 Text of Proposed…2011 3 June 2014 2:11-cv-01241-KM-MAH Patent None District Court, D. New Jersey External link to document
2013-06-06 317 Not Infringe The Asserted Claims Of U.S. Patent No. 6,284,770 Because A Single Actor Will Not Perform …2011 3 June 2014 2:11-cv-01241-KM-MAH Patent None District Court, D. New Jersey External link to document
2013-06-06 318 Testimony Of The Named Inventors Of U.S. Patent No. 6,284,770 (BIGLIN, BRIAN) (Entered: 06/06/2013) …2011 3 June 2014 2:11-cv-01241-KM-MAH Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Moodys
Johnson and Johnson
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.